Global Antibiotic Resistance Market Research Report 2021

1 Antibiotic Resistance Market Overview

• 1.1 Product Overview and Scope of Antibiotic Resistance
• 1.2 Antibiotic Resistance Segment By Disease
  • 1.2.1 Global Antibiotic Resistance Sales Growth Rate Comparison By Disease (2021-2027)
• 1.3 Antibiotic Resistance Segment by Application
  • 1.3.1 Antibiotic Resistance Sales Comparison by Application: (2021-2027)
  • 1.3.2 Oxazolidinones
  • 1.3.3 Lipoglycopeptides
  • 1.3.4 Tetracyclines
  • 1.3.5 Cephalosporins
  • 1.3.6 Combination therapies
  • 1.3.7 Other
• 1.4 Global Antibiotic Resistance Market Size Estimates and Forecasts
  • 1.4.1 Global Antibiotic Resistance Revenue 2016-2027
  • 1.4.2 Global Antibiotic Resistance Sales 2016-2027
  • 1.4.3 Antibiotic Resistance Market Size by Region: 2016 Versus 2021 Versus 2027

2 Antibiotic Resistance Market Competition by Manufacturers

• 2.1 Global Antibiotic Resistance Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Antibiotic Resistance Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Antibiotic Resistance Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Antibiotic Resistance Manufacturing Sites, Area Served, Product Type
• 2.5 Antibiotic Resistance Market Competitive Situation and Trends
  • 2.5.1 Antibiotic Resistance Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Antibiotic Resistance Players Market Share by Revenue
  • 2.5.3 Global Antibiotic Resistance Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Antibiotic Resistance Retrospective Market Scenario by Region

• 3.1 Global Antibiotic Resistance Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Antibiotic Resistance Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Antibiotic Resistance Market Facts & Figures by Country
  • 3.3.1 North America Antibiotic Resistance Sales by Country
  • 3.3.2 North America Antibiotic Resistance Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Antibiotic Resistance Market Facts & Figures by Country
  • 3.4.1 Europe Antibiotic Resistance Sales by Country
  • 3.4.2 Europe Antibiotic Resistance Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Antibiotic Resistance Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Antibiotic Resistance Sales by Region
  • 3.5.2 Asia Pacific Antibiotic Resistance Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Antibiotic Resistance Market Facts & Figures by Country
  • 3.6.1 Latin America Antibiotic Resistance Sales by Country
  • 3.6.2 Latin America Antibiotic Resistance Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Antibiotic Resistance Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Antibiotic Resistance Sales by Country
  • 3.7.2 Middle East and Africa Antibiotic Resistance Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Antibiotic Resistance Historic Market Analysis by Type

• 4.1 Global Antibiotic Resistance Sales Market Share by Type (2016-2021)
• 4.2 Global Antibiotic Resistance Revenue Market Share by Type (2016-2021)
• 4.3 Global Antibiotic Resistance Price by Type (2016-2021)

5 Global Antibiotic Resistance Historic Market Analysis by Application

• 5.1 Global Antibiotic Resistance Sales Market Share by Application (2016-2021)
• 5.2 Global Antibiotic Resistance Revenue Market Share by Application (2016-2021)
• 5.3 Global Antibiotic Resistance Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Allergan
  • 6.1.1 Allergan Corporation Information
  • 6.1.2 Allergan Description and Business Overview
  • 6.1.3 Allergan Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Allergan Product Portfolio
  • 6.1.5 Allergan Recent Developments/Updates
• 6.2 AmpliPhi Biosciences
  • 6.2.1 AmpliPhi Biosciences Corporation Information
  • 6.2.2 AmpliPhi Biosciences Description and Business Overview
  • 6.2.3 AmpliPhi Biosciences Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 AmpliPhi Biosciences Product Portfolio
  • 6.2.5 AmpliPhi Biosciences Recent Developments/Updates
• 6.3 BioVersys GmbH
  • 6.3.1 BioVersys GmbH Corporation Information
  • 6.3.2 BioVersys GmbH Description and Business Overview
  • 6.3.3 BioVersys GmbH Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 BioVersys GmbH Product Portfolio
  • 6.3.5 BioVersys GmbH Recent Developments/Updates
• 6.4 Macrolide Pharmaceuticals
  • 6.4.1 Macrolide Pharmaceuticals Corporation Information
  • 6.4.2 Macrolide Pharmaceuticals Description and Business Overview
  • 6.4.3 Macrolide Pharmaceuticals Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Macrolide Pharmaceuticals Product Portfolio
  • 6.4.5 Macrolide Pharmaceuticals Recent Developments/Updates
• 6.5 Melinta Therapeutics
  • 6.5.1 Melinta Therapeutics Corporation Information
  • 6.5.2 Melinta Therapeutics Description and Business Overview
  • 6.5.3 Melinta Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Melinta Therapeutics Product Portfolio
  • 6.5.5 Melinta Therapeutics Recent Developments/Updates
• 6.6 Merck
  • 6.6.1 Merck Corporation Information
  • 6.6.2 Merck Description and Business Overview
  • 6.6.3 Merck Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Merck Product Portfolio
  • 6.6.5 Merck Recent Developments/Updates
• 6.7 Nabriva Therapeutics
  • 6.6.1 Nabriva Therapeutics Corporation Information
  • 6.6.2 Nabriva Therapeutics Description and Business Overview
  • 6.6.3 Nabriva Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Nabriva Therapeutics Product Portfolio
  • 6.7.5 Nabriva Therapeutics Recent Developments/Updates
• 6.8 Nemesis Bioscience
  • 6.8.1 Nemesis Bioscience Corporation Information
  • 6.8.2 Nemesis Bioscience Description and Business Overview
  • 6.8.3 Nemesis Bioscience Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Nemesis Bioscience Product Portfolio
  • 6.8.5 Nemesis Bioscience Recent Developments/Updates
• 6.9 Phage Technologies S.A
  • 6.9.1 Phage Technologies S.A Corporation Information
  • 6.9.2 Phage Technologies S.A Description and Business Overview
  • 6.9.3 Phage Technologies S.A Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Phage Technologies S.A Product Portfolio
  • 6.9.5 Phage Technologies S.A Recent Developments/Updates
• 6.10 Tetraphase Pharmaceuticals
  • 6.10.1 Tetraphase Pharmaceuticals Corporation Information
  • 6.10.2 Tetraphase Pharmaceuticals Description and Business Overview
  • 6.10.3 Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Tetraphase Pharmaceuticals Product Portfolio
  • 6.10.5 Tetraphase Pharmaceuticals Recent Developments/Updates
• 6.11 The Medicines Company
  • 6.11.1 The Medicines Company Corporation Information
  • 6.11.2 The Medicines Company Antibiotic Resistance Description and Business Overview
  • 6.11.3 The Medicines Company Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 The Medicines Company Product Portfolio
  • 6.11.5 The Medicines Company Recent Developments/Updates
• 6.12 TPfizer
  • 6.12.1 TPfizer Corporation Information
  • 6.12.2 TPfizer Antibiotic Resistance Description and Business Overview
  • 6.12.3 TPfizer Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 TPfizer Product Portfolio
  • 6.12.5 TPfizer Recent Developments/Updates
• 6.13 Westway Health
  • 6.13.1 Westway Health Corporation Information
  • 6.13.2 Westway Health Antibiotic Resistance Description and Business Overview
  • 6.13.3 Westway Health Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Westway Health Product Portfolio
  • 6.13.5 Westway Health Recent Developments/Updates

7 Antibiotic Resistance Manufacturing Cost Analysis

• 7.1 Antibiotic Resistance Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Antibiotic Resistance
• 7.4 Antibiotic Resistance Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Antibiotic Resistance Distributors List
• 8.3 Antibiotic Resistance Customers

9 Antibiotic Resistance Market Dynamics

• 9.1 Antibiotic Resistance Industry Trends
• 9.2 Antibiotic Resistance Growth Drivers
• 9.3 Antibiotic Resistance Market Challenges
• 9.4 Antibiotic Resistance Market Restraints

10 Global Market Forecast

• 10.1 Antibiotic Resistance Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Antibiotic Resistance by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Antibiotic Resistance by Type (2022-2027)
• 10.2 Antibiotic Resistance Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Antibiotic Resistance by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Antibiotic Resistance by Application (2022-2027)
• 10.3 Antibiotic Resistance Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Antibiotic Resistance by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Antibiotic Resistance by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List